Private Equity
New Jersey and France-based Embleema, a healthcare blockchain network for secure sharing of personal health records, has secured $3.7 million in Series A funding. Pharmagest and Techstars led the round.
1 min read · 06 February 2019
Kennewick, Washington-based Ideal Option, a provider of medication-assisted treatment and behavioral counseling services for individuals suffering from opioid use disorder, has secured an undisclosed amount of funding. The investor was BlueCross BlueShield Venture Partners.
1 min read · 06 February 2019
Flashbreak, a new mobile game app, has secured $2 million in seed funding. The investors were Alven and Kima Ventures.
2 min read · 06 February 2019
Little Spoon, a baby food and early childhood nutrition company, has secured $7 million in funding. The investors included Vaultier7, Kairos, Interplay Ventures and SoGal Ventures.
1 min read · 05 February 2019
Palo Alto, California-based Section Partners has raised $74 million for its third fund. The investors include a fixed income investment manager, family offices, prominent venture capitalists and Silicon Valley tech executives.
3 min read · 05 February 2019
San Francisco Bay Area-based Bolt Biotherapeutics, a biotechnology company focused on the immune system, has secured $54 million in Series B financing. Pivotal bioVenture Partners led the round with participation from Nan Fung Life Sciences, Novo Holdings and Vivo Capital.
1 min read · 05 February 2019
Culver City, California-based Signal Sciences, a web application security company, has raised $35 million in Series C funding. Lead Edge Capital led the round with participation from return backers CRV, Index Ventures, Harrison Metal and OATV. In addition to the funding, Lorrie Norrington, an operating partner at Lead Edge Capital, has joined Signal Sciences’ board of directors.
1 min read · 05 February 2019
San Francisco-based MakerSights, a product decision platform for retail, has raised $3.1 million in funding. The company's investors include Steve Anderson, founder of Baseline Ventures; Hayley Barna, partner at First Round Capital; Elizabeth Spaulding, senior partner at Bain & Company; and Jeff Epstein, operating partner at Bessemer Venture Partners.
7 min read · 05 February 2019
San Diego-based Cibus Ltd, a provider of advanced plant-breeding technologies has priced its IPO of over 6.6 million shares at between $14 and $16 per share. The company plans on trading the stock on the NASDAQ under the ticker symbol "CBUS." Morgan Stanley and BofA Merrill Lynch are the lead underwriters. The company’s backers include Fidelity Management and Research Company, Alexandria Venture Investments and Cormorant Asset Management.
2 min read · 05 February 2019
Avedro Inc, an ophthalmic pharmaceutical and medical device company, has priced its IPO of 5 million shares at between $14 and $16 per share. The company plans on trading the stock on the NASDAQ under the ticker symbol "AVDR." BofA Merrill Lynch and J.P. Morgan are the lead underwriters. Avedro is backed by Lilly Asia Ventures, OrbiMed Advisors, InterWest Partners and HealthQuest Capital.
2 min read · 05 February 2019
